Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients
Clinical trial NCT00351715 · TERMINATED
Trial details
- NCT number
- NCT00351715
- Sponsor
- AHS Cancer Control Alberta
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.